Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Hayton (Manchester, United Kingdom), D. Terrington (Norwich, United Kingdom), A. Wilson (Norwich, United Kingdom), N. Chaudhuri (Manchester, United Kingdom), C. Leonard (Manchester, United Kingdom), S. Fowler (Manchester, United Kingdom). Breath Biomarkers in Idiopathic Pulmonary Fibrosis: A Systematic Review. 2921

Member's Comments

No comment yet.

Related content which might interest you: Exhaled Breath Biomarkers in Sarcoidosis: A Systematic Review Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 Cardiac MRI for Prognosis in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis Source: Virtual Congress 2020 – Imaging-based phenotyping in pulmonary disease Year: 2020 Nutritional Supplementation during Pulmonary Rehabilitation in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review Source: International Congress 2019 – Hot topics in assessment and care for chronic lung diseases Year: 2019 Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis? Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020 Systematic Review and Meta-Analysis of Endoscopic Lung Volume Reduction Using Endobronchial Valves in Severe Emphysema: Are They Better? Source: International Congress 2018 – General thoracic surgery Year: 2018 Treatment of Idiopathic Pulmonary Fibrosis - Executive Summary Source: Guideline 2015 Year: 2015 Aerobic and Breathing Exercises Improve Dyspnea, Exercise Capacity and Quality of Life in Idiopathic Pulmonary Fibrosis Patients: Systematic Review and Meta-Analysis. Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 Clinical Correlates of Physical Activity in Idiopathic Pulmonary Fibrosis (IPF) Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Treatment of Idiopathic Pulmonary Fibrosis - Evidence to Decision Frameworks Source: Guideline 2015 Year: 2015 Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis Source: International Congress 2019 – M-health/e-health I Year: 2019 Book Review: Pulmonary Hypertension Source: Eur Respir Rev 2012 21: 372 Year: 2012 Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Prognostic Factors in Patients with Idiopathic Pulmonary Fibrosis; Evaluation using Quantitative CT Analysis of Fibrosis and Emphysema Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Evaluation of Idiopathic Pulmonary Fibrosis therapies, Pirfenidone and Nintedanib, in a Human Experimental Model of Fibrosis Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Treatment of Idiopathic Pulmonary Fibrosis Source: Guideline 2015 Year: 2015 Epidemiology of Idiopathic Pulmonary Fibrosis in Australia Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021